Earnings History Data for Benitec Biopharma (BNTC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Benitec Biopharma
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | BNTC | Benitec Biopharma | 115.00 | -0.48 | -0.61 | 0.00 | Benitec GAAP EPS of -$0.48 [11/14/2024 5:29 PM] |
10.68 | 0.28 (2.69%) |
10.92 | 0.52 (5.00%) |
2.69 - 12.89 | 40,808 | 40,000 | 714 | ||
| 27-09-2024 | PM | BNTC | Benitec Biopharma Inc. | 89.60 | N/A | -0.58 | 0.00 | Benitec Non-GAAP EPS of -$5.51 [9/27/2024 1:29 AM] |
9.24 | 0.45 (5.12%) |
8.83 | 0.04 (0.46%) |
2.69 - 10.88 | 35,508 | 20,000 | 205 | ||
| 13-02-2024 | PM | BNTC | Benitec Biopharma Inc. | 7.25 | -2.64 | 0.00 | -3.40 | Benitec GAAP EPS of -$2.64 [2/13/2024 9:11 AM] |
2.85 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
1.86 - 9.01 | 3,349 | 10,000 | 0 | ||
| 21-09-2023 | AH | BNTC | Benitec Biopharma Inc. | 4.84 | N/A | 0.00 | -10.54 | Benitec reports FY results [9/21/2023 11:14 PM] |
3.09 | 0.14 (4.88%) |
0.0 | 0.0 (0.00%) |
1.86 - 9.01 | 7,640 | 30,000 | 0 | ||
| 10-11-2022 | PM | BNTC | Benitec Biopharma | 4.00 | -0.47 | -0.12 | 0.00 | Benitec GAAP EPS of -$0.47 [11/10/2022 9:06 AM] |
0.1572 | 0.01 (5.79%) |
0.16 | 0.01 (4.98%) |
0.13 - 3.66 | 118,999 | 320,000 | 464 | ||
| 16-05-2022 | PM | BNTC | Benitec Biopharma | 9.00 | -0.40 | -0.44 | 0.00 | Benitec GAAP EPS of -$0.40 beats by $0.04, revenue of $0.48M [5/16/2022 9:28 AM] |
1.06 | -0.12 (-10.46%) |
0.0 | 0.0 (0.00%) |
1.06 - 5.07 | 17,932 | 30,000 | 0 | ||
| 14-02-2022 | PM | BNTC | Benitec Biopharma Inc. | 23.78 | -117.99 | 0.00 | -99.99 | Benitec GAAP EPS of -$0.59, revenue of $25K [2/14/2022 8:18 AM] |
2.74 | -0.03 (-1.09%) |
0.0 | 0.0 (0.00%) |
2.28 - 10.49 | 21,484 | 20,000 | 0 | ||